Publikationen von Daniel Rüdiger
Alle Typen
Vortrag (17)
21.
Vortrag
Multiscale model of DIP interference and production during influenza A virus infection in animal cell culture. 4th Workshop on Virus Dynamics, Paris, France (2019)
22.
Vortrag
Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditions. 3rd Workshop on Virus Dynamics, Heidelberg, Germany (2017)
Poster (17)
23.
Poster
Genetically engineered defective interfering particles for antiviral treatment and vaccination. 28th ESACT Meeting, Edingburgh (Scotland) (2024)
24.
Poster
Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
25.
Poster
Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
26.
Poster
Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 28th ESACT Meeting, Edinburgh (Scotland) (2024)
27.
Poster
A two-dimensional model to predict coinfection of influenza A virus with defective interfering particles in tissue-like systems. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)
28.
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
29.
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 8th European Congress of Virology, Gdańsk (Poland) (2023)
30.
Poster
Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8th European Congress of Virology, Gdańsk (Poland) (2023)
31.
Poster
Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
32.
Poster
Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17th Vaccine Congress, Glasgow (Scotland) (2023)
33.
Poster
Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)
34.
Poster
Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)
35.
Poster
Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)
36.
Poster
Semi-continuous propagation of influenza A virus and its defective interfering particles - analyzing the dynamic competition to select antiviral candidates. 30th Annual Meeting of the Society for Virology, online (2021)
37.
Poster
A multiscale model of defective interfering particle replication. FOSBE 2019, Valencia, Spain (2019)
38.
Poster
A multiscale model of influenza A virus replication covering highly different infection conditions in cell cultures. Foundations of Systems Biology in Engineering - 7th FOSBE 2018, Oak Brook, Illinois, USA (2018)
39.
Poster
Stochastic multiscale modeling of influenza virus production in cell cultures. 6th IFAC Conference on Foundations of Systems Biology in Engineering (FOSBE), Magdeburg, Germany (2016)
Hochschulschrift - Doktorarbeit (1)
40.
Hochschulschrift - Doktorarbeit
Mathematical Models of Influenza A Virus Infection: Multiplicity of Infection and its Impact on Co-Infection and Virus Production. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2022)